News Daily News Experts Give Their Picks for Most Important Developments of 2011 Jason Kahn March 08, 2012
Presentation Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension Presenter: M. Brandt February 26, 2012
News Industry News ReCor Medical announces CE mark approval for its novel PARADISE™ ultrasound transcatheter renal denervation system February 19, 2012
Presentation ISET 2012 Will Renal Denervation and Other Interventions Be the Next Great Opportunity in Endovascular Therapy? Presenter: Horst Sievert January 15, 2012
Presentation TCT 2012 Catheter-Based Renal Sympathetic Denervation: Chronic Preclinical Evidence for Renal Artery Safety Presenter: Marian K. Rippy, Denise M. Zarins, Neil C. Barman, Andrew E. Wu, Keith L. Duncan, Christopher K. Zarins January 03, 2012
Presentation TCT 2012 Anatomic Substrate for Renal Sympathetic Denervation: A Human Post-Mortem Histological Study Presenter: Farrell O. Mendelsohn, Nicholas L. Deep, Daniel S. Atherton January 03, 2012
News Industry News Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011 November 04, 2011
News Daily News Endovascular Renal Nerve Ablation Safely Reduces BP During Exercise Jason Kahn August 29, 2011
News Industry News Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure July 11, 2011
News Conference News EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out May 23, 2011
News Industry News Medtronic to Release New Clinical Data on Unrivaled Portfolio of Interventional Devices at EuroPCR May 11, 2011
News Industry News Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization April 07, 2011
News Industry News Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension February 22, 2011
Partner Content Redefining Hypertension Therapy: Experience the Difference with Ultrasound Renal Denervation March 27, 2025
Video » Interview RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration November 7, 2021